Important information
Name
Recombinant Human Tumor necrosis factor receptor superfamily member 11A (TNFRSF11A), partial
Size
100ug
Catalog number
RPC24168-100ug
Price
492 €
Recombinant Human Tumor necrosis factor receptor superfamily member 11A (TNFRSF11A), partial
100ug
RPC24168-100ug
492 €
tumor
E.coli
Ice packs
TNFRSF11A
recombinants
> 90% by SDS-PAGE
6-11 business days
Recombinants or rec. proteins
For research use only. Not for diagnostic procedures.
12 months in lyophilized form; 6 months in solution form.
Short term: -20°C; Long term: -80°C. Minimize freeze and thaw cycles.
Osteoclast differentiation factor receptor; ODFRReceptor activator of NF-KB; CD265
Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.